トリテルペンを有効成分として含有する変形性関節症の予防又は治療の為の組成物
PROBLEM TO BE SOLVED: To provide a composition for prevention or treatment of osteoarthritis, and provide a composition for promoting cartilage collagen metabolism.SOLUTION: A composition according to the present invention comprises a triterpene as an active ingredient and has therefore the effects of promoting cartilage collagen metabolism, inhibiting inflammation, and reducing a pain and is effective in the prevention or treatment of osteoarthritis.SELECTED DRAWING: None.
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Europäisches Patentamt - (2021) vom: 21. Jan. Zur Gesamtaufnahme - year:2021 |
|---|
| Sprache: |
Unbestimmt |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), Last update posted on www.epo.org: 2021-01-21, Last updated: 2021-03-11 |
|---|
| Patentnummer: |
JP6547183 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA006490581 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA006490581 | ||
| 003 | DE-627 | ||
| 005 | 20230503182842.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210531s2021 xx |||||o 00| ||und c | ||
| 035 | |a (DE-627)EPA006490581 | ||
| 035 | |a (EPA)JP6547183 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a und | ||
| 245 | 1 | 0 | |a トリテルペンを有効成分として含有する変形性関節症の予防又は治療の為の組成物 |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), Last update posted on www.epo.org: 2021-01-21, Last updated: 2021-03-11 | ||
| 520 | |a PROBLEM TO BE SOLVED: To provide a composition for prevention or treatment of osteoarthritis, and provide a composition for promoting cartilage collagen metabolism.SOLUTION: A composition according to the present invention comprises a triterpene as an active ingredient and has therefore the effects of promoting cartilage collagen metabolism, inhibiting inflammation, and reducing a pain and is effective in the prevention or treatment of osteoarthritis.SELECTED DRAWING: None | ||
| 650 | 4 | |a tec | |
| 650 | 4 | |a A61K | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A23L | |
| 650 | 4 | |a A61P | |
| 650 | 4 | |a 615 | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2021) vom: 21. Jan. |
| 773 | 1 | 8 | |g year:2021 |g day:21 |g month:01 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/searchResults?DB=EPODOC&locale=en_EP&query=JP6547183B2 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | u | w | |j 2021 |b 21 |c 01 |
| 951 | |a AR | ||
| 952 | |j 2021 |b 21 |c 01 | ||